Literature DB >> 6402903

The acute encephalitic phase of neurocysticercosis: computed tomographic manifestations.

J Rodriguez-Carbajal, P Salgado, R Gutierrez-Alvarado, A Escobar-Izquierdo, C Aruffo, E Palacios.   

Abstract

Brain infestation by Cysticercus cellulosae, the larval form of Taenia solium, is a common disorder in Mexico and other Latin American countries, Asia, Africa, and some Eastern European countries. Recent immigration has caused an increase in the number of cases of neurocysticercosis in the United States. This work describes the acute encephalitic form of neurocysticercosis in 26 cases. The clinicopathologic and neuroradiologic manifestations are discussed with particular emphasis on the use of computed tomography as a main diagnosis modality which demonstrates multiple diffuse (85%) or localized (15%) enhancing nodules associated with severe edema.

Entities:  

Mesh:

Year:  1983        PMID: 6402903      PMCID: PMC8331934     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

1.  Unusual MR manifestations of neurocysticercosis.

Authors:  D C Suh; K H Chang; M H Han; S R Lee; M C Han; C W Kim
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

2.  Coexistent neurocysticercosis and Japanese B encephalitis: MR imaging correlation.

Authors:  P Singh; N Kalra; R K Ratho; S Shankar; N Khandelwal; S Suri
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 3.  Therapy of neurocysticercosis.

Authors:  J Sotelo; O H Del Brutto
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

4.  MRI in intraventricular neurocysticercosis: a case report.

Authors:  K A Hanlon; B A Vern; W S Tan; E Passen; J J Jafar
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

5.  The role of computed tomography (CT) in the diagnosis of neurocysticercosis.

Authors:  J Rodríguez-Carbajal; B Boleaga-Duran; J Dorfsman
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.